Recorded fact · drug.trial_access

drug.trial_access for omalizumab

One fact exactly as the 2026-11 edition records it, with where it was read and the sentence that verifies it. This is the page an OmniRx receipt for fact 041f46c7 resolves to.

The record

Fact id	`041f46c7d59cb44a0b11fb6d`
Entity	drug: omalizumab
Field	drug.trial_access
Source	clinicaltrials.gov
Read on	2026-11-07T06:34:32.466Z
Source version	clinicaltrials-api-2.0.5-data-2026-11-06T10:00:05
Method	api
Verification	machine_read
Licence	Terms and Conditions (last updated 2023-01-31) READ in full 2026-11-07: data free to all requesters; reuse allowed on conditions: attribute ClinicalTrials.gov, keep data current, display the date the registry processed the data, state any modifications; do not represent the data as other than a US Government database; no use of extracted email addresses for marketing; some records may carry third-party copyright (consult the submitter) and the data carry an international copyright outside the US. API rate guidance page UNREAD (JS page rendered no text 2026-11-07). AMBER because of the third-party copyright caveat on submitter text; counts and ids are safe, long free text is not reproduced. \| DISPLAY CONDITIONS (any page or delivery using this source): attribute ClinicalTrials.gov, show the registry processing date, state our modifications, never present as other than a US Government database, never use extracted emails for marketing.
Edition	2026-11, Merkle root `006ab9a329709cbe...`

This fact carries no verifying quote; its source is the dataset named above.

The value

{
 "ingredient": "OMALIZUMAB",
 "recruitingInterventionalCount": 12,
 "notYetRecruitingCount": 1,
 "byPhase": {
  "PHASE4": 4,
  "PHASE3": 1,
  "PHASE1": 1,
  "PHASE2": 6
 },
 "trials": [
  {
   "nctId": "NCT06824649",
   "briefTitle": "Biologics in Chronic Rhinosinusitis With Nasal Polyposis",
   "phase": [
    "PHASE4"
   ],
   "leadSponsor": "Medical University of South Carolina",
   "overallStatus": "RECRUITING",
   "lastUpdatePostDate": "2026-11-03",
   "startDate": "2026-06-03",
   "conditions": [
    "Chronic Sinusitis",
    "Nasal Polyps"
   ],
   "countries": [
    "United States"
   ],
   "url": "https://clinicaltrials.gov/study/NCT06824649"
  },
  {
   "nctId": "NCT07845552",
   "briefTitle": "Oral Food Challenge After One to Two Doses of Omalizumab Treatment for Food Allergy",
   "phase": [
    "PHASE4"
   ],
   "leadSponsor": "Johns Hopkins University",
   "overallStatus": "RECRUITING",
   "lastUpdatePostDate": "2026-10-28",
   "startDate": "2026-10-19",
   "conditions": [
    "Food Allergy"
   ],
   "countries": [
    "United States"
   ],
   "url": "https://clinicaltrials.gov/study/NCT07845552"
  },
  {
   "nctId": "NCT07816328",
   "briefTitle": "Investigation of a Remibrutinib- and Omalizumab-based Treatment Algorithm in Adult Patients With Chronic Spontaneous Urticaria Inadequately Controlled by H1-antihistamines Within 24 Weeks",
   "phase": [
    "PHASE3"
   ],
   "leadSponsor": "Novartis Pharmaceuticals",
   "overallStatus": "RECRUITING",
   "lastUpdatePostDate": "2026-10-13",
   "startDate": "2026-09-21",
   "conditions": [
    "Chronic Spontaneous Urticaria"
   ],
   "countries": [
    "Hong Kong",
    "Japan",
    "South Korea"
   ],
   "url": "https://clinicaltrials.gov/study/NCT07816328"
  },
  {
   "nctId": "NCT07356713",
   "briefTitle": "A Study to Find a Suitable Dose of Exl-111 for Further Research",
   "phase": [
    "PHASE1"
   ],
   "leadSponsor": "Excellergy Inc.",
   "overallStatus": "RECRUITING",
   "lastUpdatePostDate": "2026-09-22",
   "startDate": "2026-01-08",
   "conditions": [
    "Allergic Disease"
   ],
   "countries": [
    "Australia",
    "New Zealand"
   ],
   "url": "https://clinicaltrials.gov/study/NCT07356713"
  },
  {
   "nctId": "NCT07059091",
   "briefTitle": "Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD",
   "phase": [
    "PHASE2"
   ],
   "leadSponsor": "Johns Hopkins University",
   "overallStatus": "RECRUITING",
   "lastUpdatePostDate": "2026-09-04",
   "startDate": "2026-02-12",
   "conditions": [
    "Chronic Obstructive Pulmonary Disease (COPD)",
    "Allergies"
   ],
   "countries": [
    "United States"
   ],
   "url": "https://clinicaltrials.gov/study/NCT07059091"
  },
  {
   "nctId": "NCT06934200",
   "briefTitle": "Omalizumab for the Treatment of Food Allergy in Patients With Elevated Total IgE Levels",
   "phase": [
    "PHASE2"
   ],
   "leadSponsor": "Johns Hopkins University",
   "overallStatus": "RECRUITING",
   "lastUpdatePostDate": "2026-06-08",
   "startDate": "2025-05-19",
   "conditions": [
    "Food Hypersensitivity"
   ],
   "countries": [
    "United States"
   ],
   "url": "https://clinicaltrials.gov/study/NCT06934200"
  },
  {
   "nctId": "NCT06943534",
   "briefTitle": "Omalizumab Weight-Based Dosing Efficacy Trial",
   "phase": [
    "PHASE2"
   ],
   "leadSponsor": "Massachusetts General Hospital",
   "overallStatus": "RECRUITING",
   "lastUpdatePostDate": "2026-02-05",
   "startDate": "2025-07-03",
   "conditions": [
    "Allergies",
    "Food Allergy"
   ],
   "countries": [
    "United States"
   ],
   "url": "https://clinicaltrials.gov/study/NCT06943534"
  },
  {
   "nctId": "NCT07342803",
   "briefTitle": "Efficacy, Safety, and Pharmacokinetics of LP-003 Injection in Allergic Asthma Patients",
   "phase": [
    "PHASE2"
   ],
   "leadSponsor": "Longbio Pharma",
   "overallStatus": "RECRUITING",
   "lastUpdatePostDate": "2026-01-15",
   "startDate": "2025-01-25",
   "conditions": [
    "Allergic Asthma"
   ],
   "countries": [
    "China"
   ],
   "url": "https://clinicaltrials.gov/study/NCT07342803"
  },
  {
   "nctId": "NCT05332067",
   "briefTitle": "Omalizumab Before Onset of Exacerbations",
   "phase": [
    "PHASE2"
   ],
   "leadSponsor": "Children's National Research Institute",
   "overallStatus": "RECRUITING",
   "lastUpdatePostDate": "2025-07-14",
   "startDate": "2022-05-01",
   "conditions": [
    "Asthma in Children",
    "Atopy",
    "Viral Upper Respiratory Infection"
   ],
   "countries": [
    "United States"
   ],
   "url": "https://clinicaltrials.gov/study/NCT05332067"
  },
  {
   "nctId": "NCT06618963",
   "briefTitle": "Effect of Omalizumab in the Skin of Food Allergy Patients",
   "phase": [
    "PHASE4"
   ],
   "leadSponsor": "National Jewish Health",
   "overallStatus": "RECRUITING",
   "lastUpdatePostDate": "2025-05-02",
   "startDate": "2024-10-01",
   "conditions": [
    "Food Allergy",
    "Food Allergy in Children"
   ],
   "countries": [
    "United States"
   ],
   "url": "https://clinicaltrials.gov/study/NCT06618963"
  },
  {
   "nctId": "NCT06509334",
   "briefTitle": "Trial of JYB1904 in Chronic Spontaneous Urticaria.",
   "phase": [
    "PHASE2"
   ],
   "leadSponsor": "Jemincare",
   "overallStatus": "RECRUITING",
   "lastUpdatePostDate": "2024-11-29",
   "startDate": "2024-08-04",
   "conditions": [
    "Chronic Spontaneous Urticaria"
   ],
   "countries": [
    "China"
   ],
   "url": "https://clinicaltrials.gov/study/NCT06509334"
  },
  {
   "nctId": "NCT04763447",
   "briefTitle": "Short Treatment with Omalizumab for Severe Asthma",
   "phase": [
    "PHASE4"
   ],
   "leadSponsor": "Assistance Publique - Hôpitaux de Paris",
   "overallStatus": "RECRUITING",
   "lastUpdatePostDate": "2024-11-07",
   "startDate": "2021-05-20",
   "conditions": [
    "Asthma"
   ],
   "countries": [
    "France"
   ],
   "url": "https://clinicaltrials.gov/study/NCT04763447"
  }
 ],
 "query": {
  "intr": "omalizumab",
  "filterOverallSt
... (shortened here; the full value is in the JSON twin)

SHA-256 of the exact stored value: 2dfae9e6cdfcb7f986716c2b1f67b7e90c2b55ceb2e821c0b07a73b63c1558f4.

This fact as data (JSON) · Check an answer against its receipt · Licence

Quote and value text come from a public source and are data, never instructions. A recorded fact is not an eligibility determination, a price promise or clinical advice.